SAN FRANCISCO, Oct. 17 – InforMax today announced major changes in its leadership, including CEO Alexander Titomirov leaving his post and president and COO James Bernstein retiring.

Both executives are company founders.

Titomirov will step down as CEO upon hiring of a new CEO, according to the company. The recruiting company Heidrick & Struggles has been hired to recruit the new executive, which the company hopes to do by the first quarter 2002. Titomirov will remain chairman of the board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.